Advanced Solutions Life Sciences
Develops robotic 3D bioprinting systems and software for tissue engineering and regenerative medicine, enabling automated fabrication of vascularized tissues and organoids.
- CEO / Founder
- Michael Golway
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $611.9K
- Latest Round
- Undisclosed
Technology & Products
Key Products
BioAssemblyBot® 3D Biofabrication Technology Platforms, TSIM® and BioApp® Software
Technological Advantage
Patented BioAssemblyBot technology enables precise, automated tissue fabrication with vascularization capabilities, integrated with proprietary TSIM software for end-to-end workflow
Patent position
Advanced Solutions Life Sciences has filed 38 patent families across all years, compared with 5 for Allevi and 52 for CELLINK. AMPulse analysis
- Filing momentum
- 5 families filed 2022–2024, 23 in 2019–2021
- Filed in
- US 53%WO 26%EP 21%
- Named competitors, AM patent families
- Allevi 5CELLINK 52
38 AM patent families in total. Recent years are still being published, so read a filing change against the same-office figure.
Differentiation
Value Proposition
Reduces tissue model development time from months to days through automated 3D bioprinting, enabling high-throughput drug screening and accelerating regenerative medicine research.
How They Differentiate
6-axis robotic arm provides greater freedom of movement and precision compared to typical 3-axis bioprinters, integrated software platform enables automated workflow from design to fabrication
Market & Competition
Target Customers
Pharmaceutical companies, biomedical research institutions, regenerative medicine developers
Industry Verticals
Biotechnology; Pharmaceutical; Medical Research
Competitors
Allevi, CELLINK, Organovo
Growth & Milestones
Growth Metrics
23% employee growth reported; $5M-$7.9M annual revenue
Major Milestones
2013: Company founded; 2018: BioAssemblyBot patent awarded; 2019: Partnership with GE Healthcare Life Sciences; 2025: NH Tech Alliance Product of the Year award
Notable Customers
GE Healthcare Life Sciences (now Cytiva) - strategic R&D and distribution partnership; Advanced Regenerative Medical Institute (ARMI); Drug discoverers, tissue engineers, device developers, and researchers (general customer base)
AM patents
AM-relevant patents linked to this company.
- Patents
- 40
- Granted
- 15
- Families
- 38
Leading domains: process (38), equipment (30), software (9)
Filings by year: 2022: 5 · 2021: 4 · 2020: 9 · 2019: 10 · 2018: 4 · 2017: 4
- SYSTEM AND WORKSTATION FOR THE DESIGN, FABRICATION AND ASSEMBLY OF BIO-MATERIAL CONSTRUCTS03055133 · EP
- BARREL CLAMPING MECHANISMS, SYSTEMS, AND METHODS FOR 3D PRINTING2023043867 · WO
- SYSTEM AND WORKSTATION FOR THE DESIGN, FABRICATION AND ASSEMBLY OF 3-DIMENSIONAL CONSTRUCTS2019152769 · WO
- System and workstation for the design, fabrication and assembly of 3-dimensional constructs11249459 · US
- Tool for dispensing multiple materials with discrete positional control without need for sequential tool change11541597 · US
Equipment deals on record
Publicly disclosed purchases or installs only.
- BioAssemblyBot Advanced Series
USD 148,166.21
Buyer: Department of the Navy · Supplier: ADVANCED SOLUTIONS LIFE SCIENCES, LLC